11. Definitions of suspect product and illegitimate product for verification obligations under the Drug Supply Chain Security Act: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023 Subject(s): Drug IndustryLegislation, DrugDrug PackagingDrug and Narcotic ControlGovernment RegulationUnited States
12. Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023 Subject(s): Drug IndustryDrug and Narcotic ControlDrug PackagingGovernment RegulationSecurity MeasuresUnited StatesUnited States.United States.
13. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2023 Subject(s): Biological Products -- administration & dosageDrug Dosage CalculationsDrug IndustryDrug LabelingDrug PackagingGovernment RegulationInjections -- standardsPrescription Drugs -- administration & dosageProduct LabelingProduct PackagingUnited States
